Lithium’s quantum spin may shape its effects in the brain, study suggests

Lithium has been a cornerstone of psychiatric medicine for more than seven decades, yet the molecular basis of its remarkable therapeutic power has remained one of the enduring puzzles of neuroscience. Now a team at the University of Surrey has proposed an unexpected piece of the puzzle, one that comes from the strange world of quantum mechanics. In a study published in PLOS One, the researchers used computational chemistry and quantum simulations to explore whether a subtle quantum property of lithium atoms, known as nuclear spin, could influence chemical reactions involving vitamin C inside the brain. The work does not claim to have solved the mystery of how lithium treats bipolar disorder, but it offers a physically plausible mechanism that can now be put to the experimental test.

Nuclear spin is a quantum property that makes an atomic nucleus behave like a tiny magnet. Because of this, a nucleus can interact with nearby electrons and, in principle, alter the outcome of certain chemical reactions. Crucially, spin is not determined by an element’s chemical identity alone. Isotopes of the same element, which carry the same number of protons and electrons and therefore behave almost identically in ordinary chemistry, can differ in the spin of their nuclei. This means two isotopes of a drug could, in theory, produce different biological effects even though a chemist would struggle to tell them apart in a test tube. It is precisely this possibility that the Surrey team set out to investigate for lithium.

Lithium has two stable isotopes, lithium-6 and lithium-7. Chemically, they are near indistinguishable, but their nuclei possess different quantum spins. Intriguingly, previous in vivo animal studies have reported that the two isotopes can produce different biological effects, including differences in their ability to reduce hyperactivity in rats. Those findings have long been difficult to explain within the framework of conventional chemistry, which would predict essentially identical behaviour from the two isotopes. The new study asks whether quantum spin effects could bridge that explanatory gap, providing a theoretical account of how chemically identical atoms might act differently in living systems.

To explore the question, the researchers modelled a chemical reaction involving two molecules that are abundant and biologically important in the brain. The first is flavin, a vitamin B2-derived molecule that helps proteins transfer electrons in a wide range of cellular processes. The second is a radical derived from vitamin C, meaning a form of the molecule that carries a single unpaired electron. Vitamin C is plentiful in neurons, the brain’s principal signalling cells, and helps protect the brain against oxidative stress. Its radical form has a property that makes it especially interesting from a quantum perspective: it can retain its spin state for relatively long periods, giving quantum effects a wider window of opportunity to influence the reaction before the spin information is lost.

The simulations revealed that lithium-6 and lithium-7 could indeed affect this flavin-ascorbyl radical reaction differently, and that the difference stems directly from their contrasting nuclear spins. Perhaps most strikingly, the size of the predicted isotope effect was similar in magnitude to the effects inferred from the earlier animal studies comparing the behavioural consequences of the two lithium isotopes. That agreement between a purely computational prediction and previously observed biological data is what elevates the work from an interesting calculation to a testable scientific hypothesis. It suggests that the quantum mechanism is not merely a theoretical curiosity but operates on a scale that could plausibly matter in biology.

Amina Mouhamed, a PhD researcher at the University of Surrey and first author of the study, described the intellectual appeal of the finding. What fascinated the team, she said, was the possibility that two almost chemically identical forms of lithium could influence biology differently because of a quantum property of their nuclei. She noted that if such a difference could affect chemical reactions and ultimately contribute to changes in behaviour, it would demonstrate a remarkable link across scales, running from atomic nuclei all the way up to biological processes. That possibility, she emphasised, remains to be tested experimentally, but confirming it could open a new avenue for treatment design, in which the action of a medicine is fine-tuned simply by changing its isotopic composition.

Senior author Dr Marco Sacchi, Associate Professor of Computational Chemistry at the University of Surrey, was careful to frame the results within their proper limits. Lithium, he said, is an extraordinary drug that has transformed the treatment of bipolar disorder, yet after decades of clinical use scientists still do not completely understand what it does at the molecular level. He stressed that the results do not show that quantum spin effects are responsible for lithium’s therapeutic action. What they do show, he explained, is that such a mechanism is physically plausible in a biologically relevant molecular system and can generate an isotope effect of the right order of magnitude. That, he argued, gives researchers a hypothesis they can now begin to test experimentally.

The significance of the work extends beyond lithium itself. It sits within the emerging field of quantum biology, which investigates whether quantum mechanical phenomena such as spin, coherence and tunnelling play functional roles in living systems. The best-known example is the proposed radical pair mechanism in bird magnetoreception, in which the spins of electron pairs in light-sensitive proteins are thought to influence how migratory birds sense Earth’s magnetic field. The Surrey study applies a similar logic to a psychiatric drug, raising the provocative question of whether quantum effects in radical pair chemistry could mediate the behavioural and clinical actions of a widely prescribed medicine. If confirmed, it would be one of the clearest demonstrations yet that nuclear spin can shape pharmacology.

The path forward, the researchers suggest, lies in targeted experiments comparing lithium-6 and lithium-7 in systems that involve vitamin C. Such studies could determine whether the isotope-dependent effects predicted by the computational model actually occur in real chemical or biological systems. Success would not only illuminate a possible mechanism behind one of psychiatry’s most important drugs but could also point toward a genuinely novel strategy in drug development: selecting isotopes to tune the quantum behaviour of a therapeutic compound. For now, the study stands as a carefully bounded but compelling proposal, connecting the spin of an atomic nucleus to the chemistry of the brain, and inviting experimentalists to find out whether that connection runs deep enough to matter for patients.

Subject of Research: Quantum nuclear spin effects of lithium isotopes on flavin-ascorbyl radical reactions relevant to brain chemistry

Article Title: Quantum study offers new insights into lithium’s effects in the brain

Article References: Quantum study offers new insights into lithium’s effects in the brain. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: lithium, bipolar disorder, quantum biology, nuclear spin, isotopes, vitamin C, flavin, radical pair, computational chemistry, neuroscience, PLOS One, University of Surrey